Advertisement

Body Dysmorphic Disorder

  • Fugen Neziroglu
  • Sony Khemlani-Patel
  • Jose A. Yaryura-Tobias

Conclusion

BDD is a very severe and chronic disorder that greatly impairs the individual. Many patients are unable to go to school or work, become homebound, suicidal and hospitalized. Most patients are secretive and do not reveal their symptoms unless asked. They are more likely to talk about social anxiety or depression rather than preoccupation with their appearance. BDD is considered part of the obsessive compulsive spectrum disorders and is treated very similarly to OCD, although BDD patients tend to have more overvalued ideas and depression. They respond to cognitive and behavior therapy as well as psychopharmacological treatment with SSRI’s. Usually a combination of all treatment modalities administered intensively, meaning several prolonged sessions is most effective.

Keywords

Anorexia Nervosa Clinical Psychiatry Obsessive Compulsive Disorder Body Dysmorphic Disorder Beck Anxiety Inventory 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders: Fourth edition-text revision. Washington, DC: American Psychiatric Association.Google Scholar
  2. Barr, L. C., Goodman, W. K., & Price, L. H. (1992). Acute exacerbation of body dysmorphic disorder during tryptophan depletion. American Journal of Psychiatry, 149, 1406–1407.PubMedGoogle Scholar
  3. Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988). The Beck Anxiety Inventory. San Antonio: Harcourt, Brace, Jovanovich, Inc.Google Scholar
  4. Beck, A. T., Steer, R. A., & Brown, G. (1996). The Beck Depression Inventory-Second Edition. San Antonio: Harcourt, Brace, & Company.Google Scholar
  5. Bienvenu, O. J., Samuels, J. F., Riddle, M. A., Hoehn-Saric, R., Liang, K-Y, Cullen, B. A. M., et al. (2000). The relationship of obsessive-compulsive disorder to possible spectrum disorders: Results from a family study.Google Scholar
  6. Bloch, S., & Glue, P. (1988). Psychotherapy and dysmorphophobia: A case report. British Journal of Psychiatry, 152, 271–274.PubMedGoogle Scholar
  7. Braddock, L. E. (1982). Dysmorphophobia in adolescence: A case report. British Journal of Psychiatry, 140, 199–201.PubMedGoogle Scholar
  8. Brady, K. T., Austin, L., & Lydiard, R. B. (1990). Body dysmorphic disorder: The relationship to obsessive compulsive disorder. Journal of Nervous and Mental Disease, 178, 538–540.PubMedGoogle Scholar
  9. Brawman-Mintzer, O., Lydiard, B., Phillips, K. A., Morton, A., Czepowicz, V., Emmanuel, N., et al. (1995). Body dysmorphic disorder in patients with anxiety disorders and major depression: A comorbidity study. American Journal of Psychiatry, 152, 1665–1667.PubMedGoogle Scholar
  10. Campisi, T. A. (1995). Exposure and response prevention in the treatment of body dysmorphic disorder. Doctoral dissertation, Hofstra University, Hempstead, NY.Google Scholar
  11. Claiborn, J., & Pedrick, C. (2002). The BDD Workbook: Overcome body dysmorphic disorder and end body image obsessions. New Harbinger Publications.Google Scholar
  12. Cohen, L. J., Kingston, P., Bell, A., Kown, J., Aronowitz, B., & Hollander, E. (2000). Co-morbid personality impairment in body dysmorphic disorder. Comprehensive Psychiatry, 41, 4–12.PubMedCrossRefGoogle Scholar
  13. Cohen, L. J., Simeon, D., Hollander, E., Stein, D. J. (1997). In Hollander and D. J. Stein (Eds.) Obsessive compulsive spectrum disorders in obsessive compulsive disorders: Diagnosis, etiology and treatment. New York: Marcel Dekker, 1997.Google Scholar
  14. Craven, J. L., & Rodin, G. M. (1987). Cyproheptadine dependence associated with an atypical somatoform disorder. Canadian Journal of Psychiatry, 32, 143–145.Google Scholar
  15. Eisen, J. L., Phillips, K. A., Baer, L., Beer, D. A., Atala, K. D., & Rasmussen, S. A. (1998). The Brown Assessment of Beliefs Scale: Reliability and validity. American Journal of Psychiatry, 155, 102–108.PubMedGoogle Scholar
  16. Frisch, M. B. (1994). The quality of life inventory. National Computer Systems, Inc.Google Scholar
  17. Geremia, G. M., & Neziroglu, F. (2001). Cognitive therapy in the treatment of body dysmorphic disorder. Clinical Psychology and Psychotherapy, 8, 243–251.CrossRefGoogle Scholar
  18. Grant, J. E., Kim, S. W., & Crow, S. J. (2001). Prevalence and clinical features of body dysmorphic disorder in adolescent and adult psychiatric inpatients. Journal of Clinical Psychiatry, 62, 517–522.PubMedCrossRefGoogle Scholar
  19. Gunstad, J. & Phillips, K. A. (2003). Axis I comorbidity in body dysmorphic disorder. Comprehensive Psychiatry, 44, 270–276.PubMedCrossRefGoogle Scholar
  20. Hanes, K. R. (1998). Neuropsychological performance in body dysmorphic disorder. Journal of the International Neuropsychological Society, 4, 167–171.PubMedCrossRefGoogle Scholar
  21. Hollander, E. (1993). Obsessive-compulsive spectrum disorders: An overview. Psychiatric Annals, 23, 355–358.Google Scholar
  22. Hollander, E., Allen, A., Kown, J., Aronowitz, B., Schmeidler, J., Wong, C., et al. (1999). Clomipramine vs. desipramine crossover trial in body dysmorphic disorder. Archives of General Psychiatry, 56, 1033–1039.PubMedCrossRefGoogle Scholar
  23. Hollander, E., Cohen, L., & Simeon, D. (1993) Body dysmorphic disorder. Psychiatric Annals, 23, 359–364.Google Scholar
  24. Hollander, E, Liebowitz, M. R., Winchel, R., Klumker, A., & Klein, D. F. (1989). Treatment of body dysmorphic disorder with serotonin reuptake blockers. American Journal of Psychiatry, 146, 768–770.PubMedGoogle Scholar
  25. Hollander, E., & Wong, C. M. (1995). Obsessive-compulsive spectrum disorders. Journal of Clinical Psychiatry, 56(Suppl. 4), 3–6.PubMedGoogle Scholar
  26. Kaplan, Z., & Lictenberg, P. (1995). Delusional disorder, somatic subtype, treated with fluvoxamine. European Journal of Psychiatry, 9, 238–241.Google Scholar
  27. Khemlani-Patel, S. (2001). Cognitive and behavioral therapy for body dysmorphic disorder: A comparative investigation. Doctoral Dissertation. Hofstra University: Hempstead, New York.Google Scholar
  28. Kozak, M. J., & Foa, E. B. (1994). Obsessions, overvalued ideas and delusions in obsessive compulsive disorder. Behavior Research and Therapy, 32, 343–353.CrossRefGoogle Scholar
  29. Marks, I., & Mishan, J. (1988). Dysmorphic avoidance with disturbed bodily perception. A pilot study of exposure therapy. British Journal of Psychiatry, 152, 674–678.PubMedGoogle Scholar
  30. McElroy, S. L., Phillips, K. A., & Keck, P. E. (1994). Obsessive compulsive spectrum disorders. Journal of Clinical Psychiatry, 55, 33–51.PubMedGoogle Scholar
  31. McElroy, S. L., Phillips, K. A., Keck, P. E., Hudson, J. I., & Pope, H. G. (1993). Body dysmorphic disorder: Does it have a psychotic subtype? Journal of Clinical Psychiatry, 54, 389–395.PubMedGoogle Scholar
  32. McKay, D., Neziroglu, F., & Yaryura-Tobias, J. A. (1997). Comparison of clinical characteristics in obsessive compulsive disorder and body dysmorphic disorder. Journal of Anxiety Disorders, 11, 447–454.PubMedCrossRefGoogle Scholar
  33. McKay, D., Todaro, J., Neziroglu, F., Campisi, T., Moritz, K., & Yaryura-Tobias, J. A. (1997). Body dysmorphic disorder: A preliminary evaluation of treatment and maintenance using exposure and response prevention. Behavior Research and Therapy, 35, 67–70.CrossRefGoogle Scholar
  34. Munjack, D. J. (1978). The behavioral treatment of dysmorphophobia. Journal of Behavior Therapy and Experimental Psychiatry, 9, 53–56.CrossRefGoogle Scholar
  35. Neziroglu F. (2004). How to apply cognitive and behavior therapy for body dysmorphic disorder. Symposium chair (Neziroglu). Body Dysmorphic Disorder: Is it a mind, body or socio-cultural problem and how do you treat it. Update. American Psychiatric Association Meeting, New York, May 2004.Google Scholar
  36. Neziroglu, F., & Khemlani-Patel, S. (2002). A review of cognitive and behavior treatment of body dysmorphic disorder. CNS Spectrums, 7, 464–471.PubMedGoogle Scholar
  37. Neziroglu, F., Khemlani-Patel, S., Hsia, C., & Yaryura-Tobias, J. A. (2001, July). Incidence of abuse in body dysmorphic disorder. Paper presented at the World Congress of Behavioral and Cognitive Therapies. Vancouver, BC, Canada.Google Scholar
  38. Neziroglu, F., Khemlani-Patel, S., Roberts, M., & Yaryura-Tobias, J. A. (2004). Prevalence of abuse in body dysmorphic disorder and obsessive compulsive disorder. Unpublished manuscript.Google Scholar
  39. Neziroglu, F., McKay, D., Todaro, J., & Yaryura-Tobias, J. A. (1996). Effect of cognitive behavior therapy on persons with body dysmorphic disorder and co-morbid axis II diagnoses. Behavior Therapy, 27, 67–77.CrossRefGoogle Scholar
  40. Neziroglu, F., McKay, D., Yaryura-Tobias, J. A. Stevens, K., & Todaro, J. (1999). The overvalued ideas scale: Development, reliability and validity in obsessive compulsive disorder. Behavior Research and Therapy, 37, 881–902.CrossRefGoogle Scholar
  41. Neziroglu, F., Stevens, K. P., McKay, D., Yaryura-Tobias, J. A. (2001). Predictive validity of the overvalued ideas scale: Outcome in obsessive-compulsive and body dysmorphic disorders. Behavior Research and Therapy, 39, 745–756.CrossRefGoogle Scholar
  42. Neziroglu, F., Stevens, K., Yaryura-Tobias, J. A. (1999). Overvalued ideas and their impact on treatment outcome. Revista Brasileira de Psiquiatria, 21, 209–216.CrossRefGoogle Scholar
  43. Neziroglu, F., & Yaryura-Tobias, J. A. (1993a). Body dysmorphic disorder: Phenomenology and case descriptions. Behavioural Psychotherapy, 21, 27–36.CrossRefGoogle Scholar
  44. Neziroglu, F., & Yaryura-Tobias, J. A. (1993b). Exposure, response prevention, and cognitive therapy in the treatment of body dysmorphic disorder. Behavior Therapy, 1993, 24, 431–438.CrossRefGoogle Scholar
  45. Neziroglu, F., & Yaryura-Tobias, J. A. (1997). A review of cognitive behavioral and pharmacological treatment of body dysmorphic disorder. Behavior Modification, 21, 324–340.PubMedGoogle Scholar
  46. O’Sullivan, R. L., Phillips, K. A., Keuthen, N. J., & Wilhelm, S. (1999). Near fatal skin picking from delusional body dysmorphic disorder responsive to fluvoxamine. Psychosomatics, 40, 79–81.PubMedGoogle Scholar
  47. Perugi, G., Akiskal, H. S., Giannotti, D., Frare, F., DiVaio, S., & Cassano, G. B. (1997). Gender related differences in body dysmorphic disorder (Dysmorphophobia). Journal of Nervous and Mental Disease, 185, 578–582.PubMedCrossRefGoogle Scholar
  48. Phillips, K. A. (1991). Body dysmorphic disorder: The distress of imagined ugliness. American Journal of Psychiatry, 148, 1138–1149.PubMedGoogle Scholar
  49. Phillips, K. A. (1996a). The Broken Mirror. New York: Oxford University Press.Google Scholar
  50. Phillips, K. A. (1996b). Body dysmorphic disorder: Diagnosis and treatment of imagined ugliness. Journal of Clinical Psychiatry, 57(Suppl. 8), 61–64.PubMedGoogle Scholar
  51. Phillips, K. A. (1996c). Pharmacological treatment of body dysmorphic disorder. Psychopharmacology Bulletin, 32, 597–605.PubMedGoogle Scholar
  52. Phillips, K. A. (2000). Quality of life for patients with body dysmorphic disorder. Journal of Nervous and Mental Disease, 188, 170–175.PubMedCrossRefGoogle Scholar
  53. Phillips, K. A. (2002). Pharmacologic treatment of body dysmorphic disorder: Review of the evidence and a recommended treatment approach. CNS Spectrum, 7, 453–463.Google Scholar
  54. Phillips, K. A. (2004). Psychosis in body dysmorphic disorder. Journal of Psychiatric Research, 38, 63–72.PubMedCrossRefGoogle Scholar
  55. Phillips, K. A., Albertini, R. S., Siniscalchi, J. M., Khan, A., & Robinson, M. (2001). Effectiveness of pharmacotherapy for body dysmorphic disorder: A chart review study. Journal of Clinical Psychiatry, 62, 721–727.PubMedCrossRefGoogle Scholar
  56. Phillips, K. A., & Diaz, S. F. (1997). Gender differences in body dysmorphic disorder. The Journal of Nervous and Mental Disease, 185, 570–577.PubMedCrossRefGoogle Scholar
  57. Phillips, K. A., Dwight, M. M., & McElroy, S. L. (1998). Efficacy and safety of fluvoxamine in body dysmorphic disorder. Journal of Clinical Psychiatry, 59, 165–171.PubMedGoogle Scholar
  58. Phillips, K. A., Hollander, E., Rasmussen, S. A., Aronowitz, B. R., DeCaria, C., & Goodman, W. K. (1997). A severity rating scale for body dysmorphic disorder: Development, reliability, and validity of a modified version of the Yale brown obsessive compulsive scale. Psychopharmacology Bulletin, 33, 17–22.PubMedGoogle Scholar
  59. Phillips, K. A. & McElroy, S. (2000). Personality disorders and traits in patients with body dysmorphic disorder. Comprehensive Psychiatry, 41, 229–236.PubMedCrossRefGoogle Scholar
  60. Phillips, K. A., McElroy, S. L., Dwightmen, M. M., Eisen, J. L., & Rasmussen, S. A. (2001). Delusionality and response to open label fluvoxamine in body dysmorphic disorder. Journal of Clinical Psychiatry, 62, 87–91.PubMedCrossRefGoogle Scholar
  61. Phillips, K. A., McElroy, S. L., Keck, P. E., Pope, H. G., & Hudson, J. I. (1993). Body dysmorphic disorder: 30 cases of imagined ugliness. American Journal of Psychiatry, 150, 302–308.PubMedGoogle Scholar
  62. Phillips, K. A., O’Sullivan, R. L., & Pope, H. G. (1997). Muscle dysmorphia. Journal of Clinical Psychiatry, 58, 361.PubMedGoogle Scholar
  63. Phillips, K. A., McElroy, S. L., Keck, P. E. (1994). Psychopharmacology Bulletin, 30, 179–186.PubMedGoogle Scholar
  64. Phillips, K. A., Castle, D. J. (2002). In: Disorders of body image. Castle, D. J., Phillips, K. A. Petersfield, England: Wrightson Biomedical Publishing, Ltd, 101–120.Google Scholar
  65. Phillips, K. A., & Taub, S. L. (1995). Skin picking as a symptom of body dysmorphic disorder. Psychopharmacology Bulletin, 31, 279–288.PubMedGoogle Scholar
  66. Phillips, K. A., McElroy, S. L., Dwight, M. M. (2001). Journal of Clinical Psychiatry, 62, 87–91.PubMedCrossRefGoogle Scholar
  67. Pope, H. G., Gruber, A. J., Choi, P., Olivardia, R., & Phillips, K. A. (1997). Muscle dysmorphia: An under recognized form of body dysmorphic disorder. Psychosomatics, 38, 548–557.PubMedGoogle Scholar
  68. Rauch, S. L., Phillips, K. A., Segal, E., Makris, N., Shin, L. M., Whalen, P. J., et al. (2003). A preliminary morphometric magnetic resonance imaging study of regional brain volumes in body dysmorphic disorder. Psychiatry Research: Neuroimaging, 122, 13–19.CrossRefPubMedGoogle Scholar
  69. Rosen, J. C. (1995). The nature of body dysmorphic disorder and treatment with cognitive behavior therapy. Behavioral Practices, 2(1), 143–166.CrossRefGoogle Scholar
  70. Rosen, J. C., & Reiter, J. (1996). Development of the body dysmorphic disorder exam. Behavior Research and Therapy, 34, 755–766.CrossRefGoogle Scholar
  71. Rosen, J. C., Reiter, J., & Orosan, P. (1995). Cognitive-behavioral body image therapy for body dysmorphic disorder. Journal of Consulting and Clinical Psychology, 63, 263–269.PubMedCrossRefGoogle Scholar
  72. Roskes, E. (1999). Body dysmorphic disorder and a prosthesis. Psychosomatics, 40, 436–437.PubMedGoogle Scholar
  73. Schmidt, N. B., & Harrington, P. (1995). Cognitive-behavioral treatment of body dysmorphic disorder: A case report. Journal of Behavior Therapy and Experimental Psychiatry, 26, 161–167.PubMedCrossRefGoogle Scholar
  74. Simeon, D., Hollander, E., Stein, D. J., Cohen, L., & Aronowitz, B. (1995). Body dysmorphic disorder in the DSM-IV field trial for obsessive compulsive disorder. American Journal of Psychiatry, 152, 1207–1209.PubMedGoogle Scholar
  75. Thomas, C. S. (1984). Dysmorphophobia: A question of definition. British Journal of Psychiatry, 144, 513–516.PubMedGoogle Scholar
  76. Thomas, C. S. (1985). Disorders with overvalued ideas. British Journal of Psychiatry, 146, 215.CrossRefGoogle Scholar
  77. Veale, D. (2000). Outcome of cosmetic surgery and “DIY” surgery in patients with body dysmorphic disorder. Psychiatric Bulletin, 24, 218–221.CrossRefGoogle Scholar
  78. Veale, D. M., Boocock, A., Gournay, K., Dryden, W., Shah, F., Willson, R., et al. (1996). Body dysmorphic disorder: A survey of fifty cases. British Journal of Psychiatry, 169, 196–201.PubMedCrossRefGoogle Scholar
  79. Veale, D., Gournay, K., Dryden, W., Boocock, A., Shah, F., Willson, R., et al. (1996). Body dysmorphic disorder: A cognitive behavioural model and pilot randomized controlled trial. Behavior Research and Therapy, 34, 717–729.CrossRefGoogle Scholar
  80. Veale, D. M., & Lambrou, C. (2002). The importance of aesthetics in body dysmorphic disorder. CNS Spectrums, 7, 429–431.PubMedGoogle Scholar
  81. Wilhelm, S., Otto, M. L., Lohr, B., & Deckersbach, T. (1999). Cognitive behavioral group therapy for body dysmorphic disorder: A case series. Behavior Research and Therapy, 37, 71–75.CrossRefGoogle Scholar
  82. Wilhelm, S., Otto, M. W., Zucker, B. G., & Pollack, M. H. (1997). Prevalence of body dysmorphic disorder in patients with anxiety disorders. Journal of Anxiety Disorders, 11, 499–502.PubMedCrossRefGoogle Scholar
  83. Yaryura-Tobias, J. A., & Neziroglu, F. (1997). Obsessive Compulsive Disorders Spectrum: Pathogenesis, Diagnosis, and Treatment. Washington, DC: American Psychiatric Press, Inc.Google Scholar
  84. Yaryura-Tobias, J. A., Neziroglu, F., & Torres-Gallegos, M. (2002). Neuroanatomical correlates and somatosensorial disturbances in body dysmorphic disorder. CNS Spectrums, 7, 432–434.PubMedGoogle Scholar
  85. Zimmerman, M., & Mattia, J. I. (1998). Body dysmorphic disorder in psychiatric outpatients: Recognition, prevalence, comorbidity, demographic, and clinical correlates. Comprehensive Psychiatry, 39, 265–270.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2006

Authors and Affiliations

  • Fugen Neziroglu
  • Sony Khemlani-Patel
  • Jose A. Yaryura-Tobias

There are no affiliations available

Personalised recommendations